SARS-CoV-2 variants | ||||
---|---|---|---|---|
Variables | Alpha (n = 1,022) | Delta (n = 1,026) | Omicron BA.5 (n = 1,136) | P-value |
Deceased/ Improved patients | 479/543 (46.9/53.1%) | 674/352 (65.7/34.3%) | 297/839 (26.1/73.9%) | < 0.001* |
Mean age ± SD | 53.0 ± 12.7 | 58.0 ± 11.8 | 53.7 ± 12.9 | 0.128 |
Gender (male/female) | 525/497(51.4/48.6%) | 546/480 (53.2/46.8%) | 598/538 (52.6/47.4%) | 0.692 |
ALT, IU/L (mean ± SD) (Reference range: 5–40) | 38.5 ± 24.8 | 40.8 ± 24.7 | 35.8 ± 24.2 | 0.001 |
AST, IU/L (mean ± SD) (Reference range: 5–40) | 34.9 ± 15.5 | 34.5 ± 14.0 | 31.9 ± 14.4 | < 0.001* |
ALP, IU/L (mean ± SD) (Reference range: up to 306) | 190.2 ± 84.7 | 188.6 ± 74.0 | 177.2 ± 83.5 | < 0.001* |
Cholesterol, mg/dL (mean ± SD) (Reference range: 50–200) | 116.1 ± 34.1 | 120.5 ± 40.5 | 123.1 ± 39.4 | < 0.001* |
TG, mg/dL (mean ± SD) (Reference range: 60–165) | 124.1 ± 54.9 | 121.6 ± 48.8 | 126.9 ± 55.9 | 0.245 |
LDL, mg/dL (mean ± SD) (Reference range: up to 150) | 82.8 ± 45.1 | 85.3 ± 45.3 | 104.7 ± 48.3 | < 0.001* |
HDL, mg/dL (mean ± SD) (Reference range: > 40) | 32.5 ± 11.3 | 32.1 ± 11.5 | 33.6 ± 11.7 | 0.039* |
WBC, 109/L (mean ± SD) (Reference range: 4000–10,000) | 7627.3 ± 2843.2 | 7599.2 ± 2715.7 | 7704.9 ± 2807.7 | 0.297 |
CRP, mg/L (mean ± SD) (Reference range: < 10 mg/L Negative) | 61.6 ± 21.5 | 63.9 ± 22.0 | 60.2 ± 21.7 | 0.122 |
ESR, mm/1st h (mean ± SD) (Reference range: 0–15) | 50.1 ± 16.0 | 52.3 ± 16.0 | 49.1 ± 16.1 | 0.025 |
FBS, mg/dL (mean ± SD) (Reference range: 70–100) | 107.1 ± 41.6 | 109.8 ± 43.2 | 106.5 ± 40.7 | 0.716 |
Platelets × 1000/cumm (mean ± SD) (Reference range: 140,000–400,000) | 184 ± 71 | 185 ± 74 | 184 ± 69 | 0.994 |
Uric acid, mg/dL (mean ± SD) (Reference range: 3.6–6.8) | 4.8 ± 1.8 | 4.4 ± 1.7 | 5.2 ± 1.8 | < 0.001* |
Creatinine, mg/dL (mean ± SD) (Reference range: 0.6–1.4) | 0.9 ± 0.3 | 1.0 ± 0.3 | 0.8 ± 0.3 | < 0.001* |
qPCR Ct value | 20.1 ± 6.4 | 17.4 ± 6.1 | 21.9 ± 6.0 | < 0.001* |
25-hydroxy vitamin D, ng/mL (mean ± SD) (Sufficiency: 21–150) | 24.2 ± 12.8 | 21.8 ± 10.3 | 33.0 ± 13.4 | 0.029* |
IL10 rs1800871 | < 0.001* | |||
TT | 271 (26.5%) | 498 (48.5%) | 391 (34.4%) | |
CT | 550 (53.8%) | 377 (36.7%) | 619 (54.5%) | |
CC | 201 (19.7%) | 151 (14.8%) | 126 (11.1%) | |
IL10 rs1800872 | < 0.001* | |||
GG | 474 (46.4%) | 532 (51.9%) | 269 (23.7%) | |
GT | 396 (38.7%) | 386 (37.6%) | 711 (62.6%) | |
TT | 152 (14.9%) | 108 (10.5%) | 156 (13.7%) | |
IL10 rs1800896 | < 0.001* | |||
AA | 358 (35.0%) | 510 (49.7%) | 575 (50.6%) | |
AG | 550 (53.8%) | 338 (32.9%) | 511 (45.0%) | |
GG | 114 (11.2%) | 178 (17.4%) | 50 (4.4%) |